.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Abstract Talk
AT 73

Novel alternating Arenavirus-based vector technology encoding HBV antigens generates robust antigen-specific CD8 T cell responses and high titers of anti-HBsAg antibodies

Termin

Datum: 07.05.2023

Zeit: 10:55 – 11:10

Redezeit: 10 Min.

Diskussionszeit: 5 Min.

Ort / Stream:

Sala Biała

Session

Viral vectors

Themen

Vaccines
Viral vectors

Mitwirkende

Sarah Ahmadi-Erber (New York, NY / US), Sarah Schmidt (New York, NY / US), Stephane Daffis (Foster City, CA / US), Meron Mengistu (Foster City, CA / US), Daniela Deutschmann (New York, NY / US), Tetiana Grigoriev (Foster City, CA / US), Ruth Chu (Foster City, CA / US), Mohammad Uddin (Albany, NY / US), Moshkani Safiehkhatoon (Albany, NY / US), Michael D. Robek (Albany, NY / US), Henning Lauterbach (New York, NY / US), Klaus Orlinger (New York, NY / US), Simon P. Fletcher (Foster City, CA / US), Scott Balsitis (Foster City, CA / US)